Influence of Immunogenetic Biomarkers in the Clinical Outcome of HTLV-1 Infected Persons.
Ontology highlight
ABSTRACT: Human T-lymphotropic virus 1, a member of the Retroviridae family, causes a neglected, silent, persistent infection affecting circa 5 to 10 million people around the world, with biology, immune pathology, clinical diseases, epidemiology, and laboratory issues still unsolved. Most of the infected subjects are asymptomatic, but severe clinical disorders appear as a neurodegenerative disease (HTLV-1 associated myelopathy-HAM) or a lymphoprolipherative disorder (Adult T Leukemia/Lymphoma-ATLL) and in other target organs of the human body. HTLV-1 infections are frequently asymptomatic, but there is a large spectrum of diseases that have been described along the years. The mechanisms by which the virus interacts with the host, the different modes of response of the host to the infection, and the
SUBMITTER: Vallinoto ACR
PROVIDER: S-EPMC6893456 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA